Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2024-05-16 | Redeye | Redeye: GenovisQ1 2024 - Financials in line with expectations, strong outlook | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-05-15 | Genovis | Communiqué from Genovis AB (publ) Annual General Meeting May 15, 2024 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-05-15 | Genovis | Kommuniké från Årsstämman i Genovis AB (publ) den 15 maj 2024 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-05-15 | Genovis | Genovis AB: Interim Report January - March 2024 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-05-15 | Genovis | Genovis AB: Kvartalsrapport januari - mars 2024 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-04-24 | Genovis | Genovis AB: Genovis Annual Report 2023 published | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-24 | Genovis | Genovis AB: Genovis årsredovisning 2023 publicerad | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-09 | Genovis | Genovis AB: KALLELSE TILL ÅRSSTÄMMA 2024 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-09 | Genovis | Genovis AB: NOTICE CONVENING THE 2024 ANNUAL GENERAL MEETING | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-14 | Genovis | Genovis AB: Carthesian Therapeutics terminates Genovis Licence Agreement | Pressreleaser | Ladda ner | Visa Stäng |
Pressreleaser |
Genovis AB: Carthesian Therapeutics terminates Genovis Licence AgreementSubstantial resources have already been invested in the project, which now will be for the benefit of Genovis, amongst other items second and third generation of the Xork enzyme with corresponding patent applications. Currently there are no known pre-clinical or clinical data that suggest that there should not be future opportunities for therapeutic applications of Xork. ”We will now regain full rights to our proprietary Xork enzyme and we can now act on business opportunities with other partners within gene therapy and autoimmune diseases. We have several ongoing partner discussions and we have learned there is a great interest in finding new solutions to neutralizing antibodies.” says Fredrik Olsson, CEO, Genovis. This disclosure contains information that Genovis AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 14-03-2024 17:26 CET. |
||||
2024-03-14 | Genovis | Genovis AB: Cartesian Therapeutics säger upp licensavtal med Genovis | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-19 | Redeye | Redeye: Genovis Q4 2023 - Soft ending but promising start | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-15 | Genovis | Genovis AB: Bokslutskommuniké januari-december 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-02-15 | Genovis | Genovis AB: Year-end report January-December 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-02-13 | Genovis | Genovis AB: Genovis to receive USD 1 million in milestone compensation related to the development of the Xork™ enzyme | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-13 | Genovis | Genovis AB: Genovis erhåller 1 miljon USD i milstolpsersättning relaterat till utvecklingen av Xork™-enzymet | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-30 | Genovis | Genovis AB byter Certified Adviser till Carnegie Investment Bank AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-30 | Genovis | Genovis AB changes Certified Adviser to Carnegie Investment Bank AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-16 | Redeye | Redeye: Genovis Q3 2023 - Solid growth and profitability, Xork timeline remains on track | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-15 | Genovis | Genovis AB: Delårsrapport januari-september 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-11-15 | Genovis | Genovis AB: Interim Report January-September 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-08-25 | Redeye | Redeye: Genovis Q2 2023 - Strong growth and expanding EBIT margin | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-24 | Genovis | Genovis AB: Halvårsrapport januari-juni 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-08-24 | Genovis | Genovis AB: Half-Yearly Report January-June 2023 | Rapporter | Ladda ner | Visa Stäng |
|